Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2009 by National Institute of Cancerología.
Recruitment status was Active, not recruiting

Study NCT00886028 Information provided by National Institute of Cancerología

First Received on April 20, 2009. Last Updated on April 21, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Mesothelioma

More general conditions related to this trial

Interventions listed in this trial

Liposomal doxorubicin
Cisplatin

Additional drug interventions recognized in this trial

Doxorubicin

More general drug interventions related to this trial

Sponsors listed in this trial